Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

David J Castle

Showing results (41-50 of 263) with videos related to

Pageof 27
Sort By:
Comprehensive Psychiatry|February 8, 2017
Attentional biases in body dysmorphic disorder (BDD): Eye-tracking using the emotional Stroop taskWei Lin Toh, David J Castle, Susan L Rossell
Journal of Cosmetic Dermatology|December 7, 2006
Body dysmorphic disorder and cosmetic dermatology: more than skin deepDavid J Castle, Katharine A Phillips, Raymond G Dufresne
Journal of Anxiety Disorders|September 13, 2015
Facial affect recognition in body dysmorphic disorder versus obsessive-compulsive disorder: An eye-tracking studyWei Lin Toh, David J Castle, Susan L Rossell
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|December 17, 2014
Smoking and mental illness. An update for psychiatristsColin P Mendelsohn, Dianne P Kirby, David J Castle
Trials|September 11, 2016
Trialling of an optimal health programme (OHP) across chronic diseaseChantal F Ski, David R Thompson, David J Castle
The Medical Journal of Australia|February 5, 2013
Echocardiographic monitoring for clozapine-associated cardiac toxicity--time for review?Stuart D Murch, David L Prior, David J Castle
Missouri Medicine|September 19, 2019
Medical Marijuana: The Australian ExperienceDavid J Castle, Nigel Strauss, Amanda Norman, et al.
The Australian and New Zealand Journal of Psychiatry|July 29, 2016
What is the future for Schneiderian first-rank symptoms, in the Diagnostic and Statistical Manual of Mental Disorders and otherwise?Wei Lin Toh, David J Castle, Susan L Rossell
Journal of Psychopharmacology (Oxford, England)|July 23, 2003
Serum clozapine levels: a review of their clinical utilityCatherine Greenwood-Smith, Dan I Lubman, David J Castle
The Australian and New Zealand Journal of Psychiatry|November 12, 2020
Challenging use of the insight specifier for body dysmorphic disorderWei Lin Toh, David J Castle, Susan L Rossell
Pageof 27

Showing results (41-50 of 263) with videos related to

Sort By:
Pageof 27
Comprehensive Psychiatry|February 8, 2017
Attentional biases in body dysmorphic disorder (BDD): Eye-tracking using the emotional Stroop taskWei Lin Toh, David J Castle, Susan L Rossell
Journal of Cosmetic Dermatology|December 7, 2006
Body dysmorphic disorder and cosmetic dermatology: more than skin deepDavid J Castle, Katharine A Phillips, Raymond G Dufresne
Journal of Anxiety Disorders|September 13, 2015
Facial affect recognition in body dysmorphic disorder versus obsessive-compulsive disorder: An eye-tracking studyWei Lin Toh, David J Castle, Susan L Rossell
Australasian Psychiatry : Bulletin of Royal Australian and New Zealand College of Psychiatrists|December 17, 2014
Smoking and mental illness. An update for psychiatristsColin P Mendelsohn, Dianne P Kirby, David J Castle
Trials|September 11, 2016
Trialling of an optimal health programme (OHP) across chronic diseaseChantal F Ski, David R Thompson, David J Castle
The Medical Journal of Australia|February 5, 2013
Echocardiographic monitoring for clozapine-associated cardiac toxicity--time for review?Stuart D Murch, David L Prior, David J Castle
Missouri Medicine|September 19, 2019
Medical Marijuana: The Australian ExperienceDavid J Castle, Nigel Strauss, Amanda Norman, et al.
The Australian and New Zealand Journal of Psychiatry|July 29, 2016
What is the future for Schneiderian first-rank symptoms, in the Diagnostic and Statistical Manual of Mental Disorders and otherwise?Wei Lin Toh, David J Castle, Susan L Rossell
Journal of Psychopharmacology (Oxford, England)|July 23, 2003
Serum clozapine levels: a review of their clinical utilityCatherine Greenwood-Smith, Dan I Lubman, David J Castle
The Australian and New Zealand Journal of Psychiatry|November 12, 2020
Challenging use of the insight specifier for body dysmorphic disorderWei Lin Toh, David J Castle, Susan L Rossell
Pageof 27